Loading…

Distinct Ligand Binding Sites in Integrin α3β1 Regulate Matrix Adhesion and Cell-Cell Contact

The integrin α3β1 mediates cellular adhesion to the matrix ligand laminin-5. A second integrin ligand, the urokinase receptor (uPAR), associates with α3β1 via a surface loop within the α3 β-propeller (residues 242-246) but outside the laminin binding region, suggesting that uPAR-integrin interaction...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of cell biology 2003-10, Vol.163 (1), p.177-188
Main Authors: Zhang, Feng, Tom, Clifford C., Kugler, Matthias C., Ching, Tsui-Ting, Kreidberg, Jordan A., Wei, Ying, Chapman, Harold A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The integrin α3β1 mediates cellular adhesion to the matrix ligand laminin-5. A second integrin ligand, the urokinase receptor (uPAR), associates with α3β1 via a surface loop within the α3 β-propeller (residues 242-246) but outside the laminin binding region, suggesting that uPAR-integrin interactions could signal differently from matrix engagement. To explore this, α 3-/- epithelial cells were reconstituted with wild-type (wt) α3 or α3 with Ala mutations within the uPAR-interacting loop (H245A or R244A). Wt or mutant-bearing cells showed comparable expression and adhesion to laminin-5. Cells expressing wt α3 and uPAR dissociated in culture, with increased Src activity, up-regulation of SLUG, and down-regulation of E-cadherin and γ-catenin. Src kinase inhibition or expression of Src 1-251 restored the epithelial phenotype. The H245A and R244A mutants were unaffected by coexpression of uPAR. We conclude that α3β1 regulates both cell-cell contact and matrix adhesion, but through distinct protein interaction sites within its β-propeller. These studies reveal an integrin- and Src-dependent pathway for SLUG expression and mesenchymal transition.
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200304065